Previous close | 65.24 |
Open | 65.03 |
Bid | 64.89 x 800 |
Ask | 75.68 x 800 |
Day's range | 65.03 - 65.85 |
52-week range | 49.37 - 65.87 |
Volume | |
Avg. volume | 1,321,831 |
Market cap | 8.793B |
Beta (5Y monthly) | 0.94 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.96 |
Earnings date | 30 Apr 2024 |
Forward dividend & yield | 0.60 (0.92%) |
Ex-dividend date | 14 Mar 2024 |
1y target est | 74.80 |
KBR (KBR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
KBR (NYSE: KBR) announced today it has been awarded a contract by SABIC Fujian Petrochemicals to license KBR's market-leading phenol technology in China.
KBR (KBR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.